Global Digital Neuro Biomarkers Market Insights Forecasts to 2033

• The Global Digital Neuro Biomarkers Market Size Was Valued at USD 567.2 Million in 2023
• The Market Size is Growing at a CAGR of 24.7% from 2023 to 2033
• The Worldwide Digital Neuro Biomarkers Market Size is Expected to Reach USD 5188.2 Million by 2033
• Europe is Expected to Grow the fastest during the forecast period.

The Global Digital Neuro Biomarkers Market Size is Anticipated to Exceed USD 5188.2 Million by 2033, Growing at a CAGR of 24.7% from 2023 to 2033.

Market Overview

Digital biomarkers are behavioral, clinical, or physiological markers that digital technology can measure and investigate. They are created using data collected by wearable sensors, smartphones, and other digital devices to provide real-time insights into an individual's health and well-being. In neurology, digital biomarkers uninterruptedly monitor metrics like movement, speech patterns, and cognitive abilities; digital biomarkers can provide critical insights into the progression of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis. This approach has transformed the way neurological conditions such as Alzheimer's, Parkinson's, multiple sclerosis, and mental health disorders are monitored and diagnosed. Digital neuro biomarkers enable earlier symptom detection and personalized treatment plans, resulting in better patient outcomes. Wearable devices, for example, can detect changes in walking patterns or hand tremors early in the progression of Parkinson's disease. Additionally, these biomarkers provide a non-invasive, scalable, and cost-effective method for tracking brain health over time, whether in a clinical setting or remotely. The increasing use of artificial intelligence and machine learning to analyze digital neuro biomarkers expands their potential, providing more precise insights into brain health and enabling proactive management of neurological conditions.

Report Coverage

This research report categorizes the market for the global digital neuro biomarkers market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global digital neuro biomarkers market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global digital neuro biomarkers market.

Driving Factors

Increased Occurrence of Neurological Disorders

The increasing prevalence of neurological disorders like Alzheimer's, Parkinson's disease, and multiple sclerosis is a significant driver of the digital neuro biomarkers market. As the world's population ages, the number of people affected by these conditions increases, necessitating the urgent development of better diagnostic and monitoring tools. Traditional methods of diagnosing and tracking neurological diseases frequently require costly, invasive, and time-consuming procedures such as MRIs or clinical tests. Digital neuro biomarkers provide a more accessible and non-invasive alternative by continuously tracking cognitive and motor functions via smartphones, wearables, and other digital tools. This real-time data enables earlier diagnosis, personalized treatments, and accurate long-term disease progression monitoring.

Restraining Factors

Data Privacy and Security Concerns

As these technologies collect sensitive neurological and behavioral data, there is growing concern that this information will be misused or inadequately protected, resulting in potential breaches of personal health data and decreased trust in digital healthcare solutions.

Market Segmentation

The global digital neuro biomarkers market share is classified into type, clinical practice, and end-use.

• The wearable segment is expected to hold the largest share of the global digital neuro biomarkers market during the forecast period.   

Based on the type, the global digital neuro biomarkers market is categorized into wearable, mobile-based applications, sensors, and others. Among these, the wearable segment is expected to hold the largest share of the global digital neuro biomarkers market during the forecast period. Consumers are increasingly interested in wearables that can track real-time data. The demand for new wearable devices is expected to increase as producers continue to launch innovative wearables and smart devices. For example, Revibe Technologies' Wearable Reminder System, a smartwatch technology that measures on-task behavior and sends coaching reminders during off-task behavior, can assist children with ADHD in regaining focus.

• The diagnostic digital neuro biomarkers segment is expected to grow at the fastest CAGR during the forecast period.  

Based on clinical practice, the global digital neuro biomarkers market is categorized into diagnostic digital neuro biomarkers, monitoring digital neuro biomarkers, predictive and prognostic digital neuro biomarkers, and others. Among these, the diagnostic digital neuro biomarkers segment is expected to grow at the fastest CAGR during the forecast period. A diagnostic biomarker helps to detect or confirm the presence of a specific disease or condition, as well as to identify a specific subtype of the disease. These biomarkers are used to diagnose patients and redefine disease classification. To maintain their market position, key companies are increasing the number of products they launch in this segment.

The healthcare companies segment is expected to grow at the fastest CAGR during the forecast period. 

Based on the end-use, the global digital neuro biomarkers market is categorized into healthcare companies, healthcare providers, payers, and others. Among these, the healthcare companies segment is expected to grow at the fastest CAGR during the forecast period. Digital biomarkers enable continuous monitoring and personalized treatment plans, which are critical for managing conditions that necessitate regular evaluation, such as cardiovascular disease and neurodegenerative disorders. The use of digital tools such as wearables and mobile applications has allowed healthcare providers to collect and analyze patient data more proficiently, resulting in better patient outcomes and lower healthcare costs. Additionally, the relationship between healthcare companies and technology inventors has enhanced the development and adoption of digital biomarkers, strengthening their market position.

Regional Segment Analysis of the Global Digital Neuro Biomarkers Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is projected to hold the largest share of the global digital neuro biomarkers market over the forecast period.

North America is projected to hold the largest share of the global digital neuro biomarkers market over the forecast period. The high prevalence of neurological disorders, an aging population, significant healthcare spending on neurological treatments, and favorable reimbursement policies for neuro-diagnostic procedures are all expected to drive market growth. The digital neuro biomarkers market in the U.S. accounted for a sizable portion of the North American market, owing to significant investments in advanced technologies by key market players and technological advancements in the neuroscience sector.

Europe is expected to grow at the fastest CAGR growth of the global digital neuro biomarkers market during the forecast period. Advances in digital health technologies and a growing emphasis on personalized medicine. These biomarkers, derived from digital platforms like wearable devices, mobile apps, and advanced imaging techniques, enable real-time and precise monitoring of neurological conditions. This allows for earlier diagnosis, better patient outcomes, and more effective management of diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. The addition of AI and machine learning to these digital tools improves their predictive accuracy and analytical capabilities. Supportive regulatory frameworks, increased investments in healthcare technology, and collaborations between tech companies and healthcare providers are all driving the market's growth across Europe.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global digital neuro biomarkers market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Altoida Inc.
• Koneksa
• Biogen Inc.
• Roche (Navify)
• NeuraMetrix
• Merck KGaA
• Linus Health
• Neurotrack Technologies, Inc.
• Huma
• NeuraLight
• RCSI
• Qiagen
• ADx NeuroSciences NV
• Enrolmmun
• Thermo Fisher Scientific
• Others

Key Market Developments

• In May 2024, RCSI collaborated with Dublin-based Head Diagnostics on a clinical study to improve multiple sclerosis (MS) assessment and monitoring using innovative technology. The study, which was launched to coincide with World MS Day, will look into the use of novel digital biomarkers to monitor disease, to provide greater objectivity in assessing the condition.

• In March 2024, Indivi, a well-known MedTech company headquartered in Basel, Switzerland, announced a collaboration with Biogen to advance digital health technologies and develop digital biomarkers for Parkinson's disease.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global digital neuro biomarkers market based on the below-mentioned segments: 

Global Digital Neuro Biomarkers Market, By Type

• Wearable
• Mobile Based Applications
• Sensors
• Others

Global Digital Neuro Biomarkers Market, By Clinical Practice

• Diagnostic Digital Neuro Biomarkers
• Monitoring Digital Neuro Biomarkers
• Predictive and Prognostic Digital Neuro Biomarkers
• Others

Global Digital Neuro Biomarkers Market, By End-use

• Healthcare Companies
• Healthcare Providers
• Payers
• Others

Global Digital Neuro Biomarkers Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa